CM
Caption Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.64M | Buy |
237,500
+58,672
| +33% | +$2.13M | 0.1% | 21 |
|
|
2025
Q1 | $6.48M | Buy |
178,828
+61,257
| +52% | +$2.22M | 0.06% | 33 |
|
|
2024
Q4 | $4.95M | Buy |
117,571
+108,971
| +1,267% | +$4.58M | 0.05% | 42 |
|
|
2024
Q3 | $478K | Buy |
+8,600
| New | +$478K | 0.01% | 236 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 743 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 826 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 790 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 731 |
|
|
2023
Q2 | – | Sell |
-18,024
| Closed | -$723K | – | 686 |
|
|
2023
Q1 | $723K | Buy |
18,024
+12,524
| +228% | +$502K | 0.01% | 143 |
|
|
2022
Q4 | $255K | Sell |
5,500
-46,300
| -89% | -$2.15M | ﹤0.01% | 275 |
|
|
2022
Q3 | $2.15M | Buy |
51,800
+51,766
| +152,253% | +$2.14M | 0.03% | 56 |
|
|
2022
Q2 | $2K | Buy |
+34
| New | +$2K | ﹤0.01% | 472 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 896 |
|
|
2021
Q2 | – | Sell |
-10,801
| Closed | -$1.23M | – | 739 |
|
|
2021
Q1 | $1.23M | Buy |
+10,801
| New | +$1.23M | 0.03% | 149 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 583 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 583 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 562 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 404 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 349 |
|